UCB, Inc., et al. v. Accord Healthcare, Inc. et al , C.A. No. 13-1206 LPS, May 14, 2015 Stark, C.J. Claim construction ruling issues on one term from the patent-in-suit. Multimedia technology tutorials had been submitted, and a claim construction ... Lexology, 2 days ago
1 images for "lacosamide"
Media reports said that the company has got tentative US FDA nod for Epilepsy drug Lacosamide.India Infoline, 3 weeks ago 3/22/15 - India,United States : AUROBINDO PHARMA gets FDA approval for LACOSAMIDE TABLETS [TendersInfo (India)] Pharmacy Choice, 2 months ago Aurobindo Pharma receives USFDA Tentative Approval for Lacosamide Tablets Equity Bulls, 2 months ago Aurobindo gets tentative nod from USFDA for Lacosamide tablets ZeeNews.com, 2 months ago
Lacosamide Tablets are the generic equivalent of USB Inc’s Vimpat Tablets and used in the treatment of partial-onset seizures in patients with epilepsy aged 17 years and older with a market size of approximately US$ 593 Million for the twelve months ending ...India Infoline, 2 months ago Aurobindo Pharma receives US FDA tentative approval for Lacosamide tabs Financial Express, 2 months ago Aurobindo gets tentative US FDA nod for Lacosamide tablets Smart Investor, 2 months ago Aurobindo gets US FDA nod for Lacosamide tablets Hindu Business Line, 2 months ago
Related to : Aurobindo Pharma Ltd Aurobindo Pharma Ltd BSE 19 Mar 15 | 03:05 PM 1239.30 -3.05 (-0.25%) NSE 19 Mar 15 | 02:54 PM 1251.00 6.05 (0.49%) Shares of Aurobindo Pharma were trading higher by 2% at Rs 1,265 on the BSE ...Smart Investor, 2 months ago Equity Report By Ways2Capital 23 March 2015 Press Release Ping, 2 months ago
LACOSAMIDE LACOSAMIDE 50MG TABLET;ORAL None (Tentative Approval) No None LACOSAMIDE ...U.S. Food and Drug Administration, 3 weeks ago
By a News Reporter-Staff News Editor at Biotech Week -- From Alexandria, Virginia , NewsRx journalists report that a patent by the inventors Kazuta, Yuji (Tsukuba, JP); Watanabe, Toru (Tsukuba, JP); Sorimachi, Keiichi (Tsukuba, JP); Saito, Minako ...4 Traders, 3 weeks ago
American Academy of Neurology Washington, April 1825, 2015 ( www.aan.com ) Alzheimer disease Results of a multicenter, double-blind, two-stage, 10-week study showed that patients with probable Alzheimer disease and clinically meaningful ...Pharmacist.com, 3 weeks ago
CMS spent $2.5 billion on the heartburn drug in 2013 on 8.2 million claims. Henry Powderly, Managing Editor The Center for Medicare and Medicaid Services spent more than $103 billion on prescription drugs in 2013 under the Medicare Part D ...Healthcare Finance News, 3 weeks ago
/PRNewswire/ --UCB, a global biopharmaceutical company focusing on neurology and immunology treatment and research, is sponsoring a total of 24 data presentations at the 67th Annual Meeting of the American Academy of Neurology (AAN) in Washington, ...Crawford Financial Planning, 1 month ago What is neuropathy? Neuropathy causes and treatments Medical News Today, 1 month ago
Sunovion Pharmaceuticals Inc. to Present Data on Aptiom® (eslicarbazepine acetate) at 67th American Academy of Neurology Annual Meeting
MARLBOROUGH, Mass.--( BUSINESS WIRE )--Sunovion Pharmaceuticals Inc. (Sunovion) will present five research posters at the 67 th American Academy of Neurology (AAN) Annual Meeting (April 18-25, Washington, D.C.), including findings from ...Business Wire, 1 month ago Sunovion Pharmaceuticals Inc. : to Present Data on Aptiom® (eslicarbazepine acetate) at 67th American Academy of Neurology Annual Meeting 4 Traders, 1 month ago
More from: , Morningstar.com...and 4 other sources
on your WebpageAdd Widget >Get your members hooked!